PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human HB-EGF (carrier-free), 25 μg
Recombinant Human Heregulin-β1 (Animal-Free), 50 μg
Recombinant Human HGF (carrier-free), 10 μg
Recombinant Human HGF (carrier-free), 2 μg
Recombinant Human HMGB1 (carrier-free), 25 µg
Recombinant Human HVEM-Fc Chimera (carrier-free), 100 μg
Recombinant Human HVEM-Fc Chimera (carrier-free), 20 μg
Recombinant Human ICAM-1-Fc Chimera (carrier-free), 100 μg
Recombinant Human ICAM-1-Fc Chimera (carrier-free), 25 μg
Recombinant Human ICOS-Fc Chimera (carrier-free), 10 μg
Recombinant Human ICOS-Fc Chimera (carrier-free), 100 μg
Recombinant Human ICOS-Fc Chimera (carrier-free), 25 μg
Recombinant Human IFN-α2 (carrier-free), 10 μg
Recombinant Human IFN-α2 (carrier-free), 100 μg
Recombinant Human IFN-α2 (carrier-free), 25 μg
Recombinant Human IFN-α2 (carrier-free), 500 μg